WikiFX

Rispondi

Based on my personal evaluation of Alfa Capital and the information available, I approach this broker with significant caution, especially regarding cost transparency on trading instruments such as the US100 index. In my years of trading experience, understanding the full spectrum of trading costs is crucial for effective risk management and profit calculation. However, Alfa Capital currently has substantial regulatory challenges, with its licenses from both CySEC and the FCA revoked. For me, this lack of oversight alone raises immediate concerns about the reliability of any published fee structures or cost disclosures. More specifically, I could not find any clear or verifiable details regarding spreads, commissions, overnight swap rates, or other costs associated with trading indices like the US100. The absence of this fundamental information is, in my view, a clear red flag, as reputable brokers typically disclose detailed trading conditions. Without regulatory supervision, there’s an increased risk that costs could be non-standard, unpredictable, or subject to change without notice. Given these realities, I would not feel comfortable trading indices or any other products with Alfa Capital at this time. The inability to access reliable and up-to-date cost information prevents me from making any informed decisions or recommendations about their fee structure for the US100 or similar indices. For my capital safety and trade planning, I require full transparency and trustworthy regulation—both of which Alfa Capital demonstrably lacks at present.